Galectin Therapeutics Reports Q3 2019 Financial Results
Go back to Galectin Therapeutics Reports Q3 2019 Financial Results| GALECTIN (NASDAQ: GALT) | Delayed: 3.71 +0.19 (5.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.52 | 52 Week High | $3.05 | |||
| Open | $3.54 | 52 Week Low | $0.49 | |||
| Day High | $3.77 | P/E | N/A | |||
| Day Low | $3.54 | EPS | $-1.32 | |||
| Volume | 121,512 | |||||

